T cell Response in Q fever (TRIQ-study)

Completed

• Conditions: Q fever; 10039135

• Registration Number: NL-OMON35925
• Lead Sponsor: Diakonessenhuis Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

-history of Q fever =/> 6 months: clinically compatible illness with serologically proven Coxiella burnetii infection.
-10 Q fever patients, no sequelae
-10 QFS patients (diagnosis: CFS as diagnosed using the 1994 CDC criteria)
-10 chronic Q fever patients
-10 seronegative controls
-informed consent

Exclusion Criteria

- clinically significant co-morbidity (not for chronic Q fever patients)
- immunosuppressive medication
- < 18 years

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Results of the Coxiella ELISPOT assay for the different Q fever outcome groups. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>N/A</p><br>